List of Tables
Table 1. Global NK-1 Receptor Antagonists Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global NK-1 Receptor Antagonists Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global NK-1 Receptor Antagonists Market Competitive Situation by Manufacturers in 2024
Table 4. Global NK-1 Receptor Antagonists Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global NK-1 Receptor Antagonists Sales Market Share by Manufacturers (2020-2025)
Table 6. Global NK-1 Receptor Antagonists Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global NK-1 Receptor Antagonists Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market NK-1 Receptor Antagonists Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of NK-1 Receptor Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of NK-1 Receptor Antagonists, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of NK-1 Receptor Antagonists, Product Type & Application
Table 12. Global Key Manufacturers of NK-1 Receptor Antagonists, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global NK-1 Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK-1 Receptor Antagonists as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global NK-1 Receptor Antagonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global NK-1 Receptor Antagonists Sales by Region (2020-2025) & (K Units)
Table 18. Global NK-1 Receptor Antagonists Sales Market Share by Region (2020-2025)
Table 19. Global NK-1 Receptor Antagonists Sales by Region (2026-2031) & (K Units)
Table 20. Global NK-1 Receptor Antagonists Sales Market Share by Region (2026-2031)
Table 21. Global NK-1 Receptor Antagonists Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global NK-1 Receptor Antagonists Revenue Market Share by Region (2020-2025)
Table 23. Global NK-1 Receptor Antagonists Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global NK-1 Receptor Antagonists Revenue Market Share by Region (2026-2031)
Table 25. North America NK-1 Receptor Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America NK-1 Receptor Antagonists Sales by Country (2020-2025) & (K Units)
Table 27. North America NK-1 Receptor Antagonists Sales by Country (2026-2031) & (K Units)
Table 28. North America NK-1 Receptor Antagonists Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America NK-1 Receptor Antagonists Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe NK-1 Receptor Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe NK-1 Receptor Antagonists Sales by Country (2020-2025) & (K Units)
Table 32. Europe NK-1 Receptor Antagonists Sales by Country (2026-2031) & (K Units)
Table 33. Europe NK-1 Receptor Antagonists Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe NK-1 Receptor Antagonists Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific NK-1 Receptor Antagonists Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific NK-1 Receptor Antagonists Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific NK-1 Receptor Antagonists Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific NK-1 Receptor Antagonists Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific NK-1 Receptor Antagonists Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America NK-1 Receptor Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America NK-1 Receptor Antagonists Sales by Country (2020-2025) & (K Units)
Table 42. Latin America NK-1 Receptor Antagonists Sales by Country (2026-2031) & (K Units)
Table 43. Latin America NK-1 Receptor Antagonists Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America NK-1 Receptor Antagonists Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa NK-1 Receptor Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa NK-1 Receptor Antagonists Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa NK-1 Receptor Antagonists Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa NK-1 Receptor Antagonists Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa NK-1 Receptor Antagonists Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global NK-1 Receptor Antagonists Sales (K Units) by Type (2020-2025)
Table 51. Global NK-1 Receptor Antagonists Sales (K Units) by Type (2026-2031)
Table 52. Global NK-1 Receptor Antagonists Sales Market Share by Type (2020-2025)
Table 53. Global NK-1 Receptor Antagonists Sales Market Share by Type (2026-2031)
Table 54. Global NK-1 Receptor Antagonists Revenue (US$ Million) by Type (2020-2025)
Table 55. Global NK-1 Receptor Antagonists Revenue (US$ Million) by Type (2026-2031)
Table 56. Global NK-1 Receptor Antagonists Revenue Market Share by Type (2020-2025)
Table 57. Global NK-1 Receptor Antagonists Revenue Market Share by Type (2026-2031)
Table 58. Global NK-1 Receptor Antagonists Price (US$/Unit) by Type (2020-2025)
Table 59. Global NK-1 Receptor Antagonists Price (US$/Unit) by Type (2026-2031)
Table 60. Global NK-1 Receptor Antagonists Sales (K Units) by Application (2020-2025)
Table 61. Global NK-1 Receptor Antagonists Sales (K Units) by Application (2026-2031)
Table 62. Global NK-1 Receptor Antagonists Sales Market Share by Application (2020-2025)
Table 63. Global NK-1 Receptor Antagonists Sales Market Share by Application (2026-2031)
Table 64. Global NK-1 Receptor Antagonists Revenue (US$ Million) by Application (2020-2025)
Table 65. Global NK-1 Receptor Antagonists Revenue (US$ Million) by Application (2026-2031)
Table 66. Global NK-1 Receptor Antagonists Revenue Market Share by Application (2020-2025)
Table 67. Global NK-1 Receptor Antagonists Revenue Market Share by Application (2026-2031)
Table 68. Global NK-1 Receptor Antagonists Price (US$/Unit) by Application (2020-2025)
Table 69. Global NK-1 Receptor Antagonists Price (US$/Unit) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Merck NK-1 Receptor Antagonists Product
Table 74. Merck Recent Developments/Updates
Table 75. TerSera Therapeutics Company Information
Table 76. TerSera Therapeutics Description and Business Overview
Table 77. TerSera Therapeutics NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. TerSera Therapeutics NK-1 Receptor Antagonists Product
Table 79. TerSera Therapeutics Recent Developments/Updates
Table 80. Helsinn Healthcare Company Information
Table 81. Helsinn Healthcare Description and Business Overview
Table 82. Helsinn Healthcare NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Helsinn Healthcare NK-1 Receptor Antagonists Product
Table 84. Helsinn Healthcare Recent Developments/Updates
Table 85. Heron Therapeutics Company Information
Table 86. Heron Therapeutics Description and Business Overview
Table 87. Heron Therapeutics NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Heron Therapeutics NK-1 Receptor Antagonists Product
Table 89. Heron Therapeutics Recent Developments/Updates
Table 90. Sandoz Company Information
Table 91. Sandoz Description and Business Overview
Table 92. Sandoz NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Sandoz NK-1 Receptor Antagonists Product
Table 94. Sandoz Recent Developments/Updates
Table 95. Glenmark Company Information
Table 96. Glenmark Description and Business Overview
Table 97. Glenmark NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Glenmark NK-1 Receptor Antagonists Product
Table 99. Glenmark Recent Developments/Updates
Table 100. Torrent Pharmaceuticals Company Information
Table 101. Torrent Pharmaceuticals Description and Business Overview
Table 102. Torrent Pharmaceuticals NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Torrent Pharmaceuticals NK-1 Receptor Antagonists Product
Table 104. Torrent Pharmaceuticals Recent Developments/Updates
Table 105. Steriscience Company Information
Table 106. Steriscience Description and Business Overview
Table 107. Steriscience NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Steriscience NK-1 Receptor Antagonists Product
Table 109. Steriscience Recent Developments/Updates
Table 110. Mylan Company Information
Table 111. Mylan Description and Business Overview
Table 112. Mylan NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Mylan NK-1 Receptor Antagonists Product
Table 114. Mylan Recent Developments/Updates
Table 115. Fresenius Kabi Company Information
Table 116. Fresenius Kabi Description and Business Overview
Table 117. Fresenius Kabi NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Fresenius Kabi NK-1 Receptor Antagonists Product
Table 119. Fresenius Kabi Recent Developments/Updates
Table 120. MSN Company Information
Table 121. MSN Description and Business Overview
Table 122. MSN NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. MSN NK-1 Receptor Antagonists Product
Table 124. MSN Recent Developments/Updates
Table 125. Teva Company Information
Table 126. Teva Description and Business Overview
Table 127. Teva NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Teva NK-1 Receptor Antagonists Product
Table 129. Teva Recent Developments/Updates
Table 130. Eugia Pharma Company Information
Table 131. Eugia Pharma Description and Business Overview
Table 132. Eugia Pharma NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Eugia Pharma NK-1 Receptor Antagonists Product
Table 134. Eugia Pharma Recent Developments/Updates
Table 135. Lupin Company Information
Table 136. Lupin Description and Business Overview
Table 137. Lupin NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Lupin NK-1 Receptor Antagonists Product
Table 139. Lupin Recent Developments/Updates
Table 140. Dr. Reddy's Laboratories Company Information
Table 141. Dr. Reddy's Laboratories Description and Business Overview
Table 142. Dr. Reddy's Laboratories NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Dr. Reddy's Laboratories NK-1 Receptor Antagonists Product
Table 144. Dr. Reddy's Laboratories Recent Developments/Updates
Table 145. Chia Tai Tianqing Pharmaceutical Company Information
Table 146. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 147. Chia Tai Tianqing Pharmaceutical NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Chia Tai Tianqing Pharmaceutical NK-1 Receptor Antagonists Product
Table 149. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 150. Qilu Pharmaceutical Company Information
Table 151. Qilu Pharmaceutical Description and Business Overview
Table 152. Qilu Pharmaceutical NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Qilu Pharmaceutical NK-1 Receptor Antagonists Product
Table 154. Qilu Pharmaceutical Recent Developments/Updates
Table 155. Beijing Sihuan Pharmaceutical Company Information
Table 156. Beijing Sihuan Pharmaceutical Description and Business Overview
Table 157. Beijing Sihuan Pharmaceutical NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Beijing Sihuan Pharmaceutical NK-1 Receptor Antagonists Product
Table 159. Beijing Sihuan Pharmaceutical Recent Developments/Updates
Table 160. Yichang Humanwell Pharmaceutical Company Information
Table 161. Yichang Humanwell Pharmaceutical Description and Business Overview
Table 162. Yichang Humanwell Pharmaceutical NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Yichang Humanwell Pharmaceutical NK-1 Receptor Antagonists Product
Table 164. Yichang Humanwell Pharmaceutical Recent Developments/Updates
Table 165. Hansoh Pharma Company Information
Table 166. Hansoh Pharma Description and Business Overview
Table 167. Hansoh Pharma NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Hansoh Pharma NK-1 Receptor Antagonists Product
Table 169. Hansoh Pharma Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. NK-1 Receptor Antagonists Distributors List
Table 173. NK-1 Receptor Antagonists Customers List
Table 174. NK-1 Receptor Antagonists Market Trends
Table 175. NK-1 Receptor Antagonists Market Drivers
Table 176. NK-1 Receptor Antagonists Market Challenges
Table 177. NK-1 Receptor Antagonists Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of NK-1 Receptor Antagonists
Figure 2. Global NK-1 Receptor Antagonists Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global NK-1 Receptor Antagonists Market Share by Type: 2024 & 2031
Figure 4. Aprepitant Product Picture
Figure 5. Rolapitant Product Picture
Figure 6. Fosaprepitant Product Picture
Figure 7. Netupitant Product Picture
Figure 8. Maropitant Product Picture
Figure 9. Other Product Picture
Figure 10. Global NK-1 Receptor Antagonists Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global NK-1 Receptor Antagonists Market Share by Application: 2024 & 2031
Figure 12. Chemotherapy-induced Nausea and Vomiting (CINV)
Figure 13. Postoperative Nausea and Vomiting (PONV)
Figure 14. Other
Figure 15. Global NK-1 Receptor Antagonists Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global NK-1 Receptor Antagonists Market Size (2020-2031) & (US$ Million)
Figure 17. Global NK-1 Receptor Antagonists Sales (2020-2031) & (K Units)
Figure 18. Global NK-1 Receptor Antagonists Average Price (US$/Unit) & (2020-2031)
Figure 19. NK-1 Receptor Antagonists Report Years Considered
Figure 20. NK-1 Receptor Antagonists Sales Share by Manufacturers in 2024
Figure 21. Global NK-1 Receptor Antagonists Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest NK-1 Receptor Antagonists Players: Market Share by Revenue in NK-1 Receptor Antagonists in 2024
Figure 23. NK-1 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global NK-1 Receptor Antagonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America NK-1 Receptor Antagonists Sales Market Share by Country (2020-2031)
Figure 26. North America NK-1 Receptor Antagonists Revenue Market Share by Country (2020-2031)
Figure 27. United States NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe NK-1 Receptor Antagonists Sales Market Share by Country (2020-2031)
Figure 30. Europe NK-1 Receptor Antagonists Revenue Market Share by Country (2020-2031)
Figure 31. Germany NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific NK-1 Receptor Antagonists Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific NK-1 Receptor Antagonists Revenue Market Share by Region (2020-2031)
Figure 38. China NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. China Taiwan NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Southeast Asia NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America NK-1 Receptor Antagonists Sales Market Share by Country (2020-2031)
Figure 46. Latin America NK-1 Receptor Antagonists Revenue Market Share by Country (2020-2031)
Figure 47. Mexico NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Colombia NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa NK-1 Receptor Antagonists Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa NK-1 Receptor Antagonists Revenue Market Share by Country (2020-2031)
Figure 53. Turkey NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE NK-1 Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of NK-1 Receptor Antagonists by Type (2020-2031)
Figure 57. Global Revenue Market Share of NK-1 Receptor Antagonists by Type (2020-2031)
Figure 58. Global NK-1 Receptor Antagonists Price (US$/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of NK-1 Receptor Antagonists by Application (2020-2031)
Figure 60. Global Revenue Market Share of NK-1 Receptor Antagonists by Application (2020-2031)
Figure 61. Global NK-1 Receptor Antagonists Price (US$/Unit) by Application (2020-2031)
Figure 62. NK-1 Receptor Antagonists Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
